BALAXI PHARMACEUTICALS Quarterly Results
| Consolidated | Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 Audited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 Audited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹73 Cr | ₹56 Cr | ₹71 Cr | ₹76 Cr | ₹73 Cr | ₹77 Cr | ₹66 Cr | ₹60 Cr |
| Expenses | ₹69 Cr | ₹55 Cr | ₹67 Cr | ₹64 Cr | ₹69 Cr | ₹67 Cr | ₹56 Cr | ₹46 Cr |
| Operating Income | ₹3 Cr | ₹1 Cr | ₹4 Cr | ₹13 Cr | ₹4 Cr | ₹11 Cr | ₹10 Cr | ₹13 Cr |
| Other Income | ₹0 Cr | ₹2 Cr | ₹-2 Cr | ₹-2 Cr | ₹4 Cr | ₹-4 Cr | ₹-2 Cr | ₹-2 Cr |
| Interest | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr |
| Depreciation | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr |
| Profit Before Tax | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹10 Cr | ₹6 Cr | ₹6 Cr | ₹7 Cr | ₹11 Cr |
| Profit After Tax | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹9 Cr | ₹5 Cr | ₹5 Cr | ₹6 Cr | ₹11 Cr |
| EPS | ₹0.06 | ₹0.04 | ₹0.05 | ₹1.56 | ₹0.97 | ₹0.83 | ₹1.17 | ₹2.01 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| BALAXI PHARMACEUTICALS | -4.9% | -15.5% | -68.4% |
| ADANI ENTERPRISES | -4.8% | -0.6% | -2.5% |
| REDINGTON | -3.2% | -3.8% | 14.4% |
| MMTC | -3.3% | -11% | -1.8% |
| HONASA CONSUMER | 2.6% | 4.7% | 39.6% |
| LLOYDS ENTERPRISES | -5.6% | -6.6% | 22.4% |
| ENTERO HEALTHCARE SOLUTIONS | -0.7% | -4.6% | -19.3% |
| OPTIEMUS INFRACOM | -4.9% | -8.9% | -34.8% |
| POLO QUEEN INDUSTRIAL & FINTECH | -2.9% | -17.8% | -84% |
BALAXI PHARMACEUTICALS Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 29.14 % |
| Y-o-Y | -1.02 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Dec2025 | ₹73 Cr | 29.14 | |
| Sep2025 | ₹56 Cr | -20.59 | |
| Jun2025 | ₹71 Cr | -7.24 | |
| Mar2025 | ₹76 Cr | 4.06 | |
| Dec2024 | ₹73 Cr | -5.29 | |
| Sep2024 | ₹77 Cr | 17.92 | |
| Jun2024 | ₹66 Cr | 9.68 | |
| Mar2024 | ₹60 Cr | - | |
BALAXI PHARMACEUTICALS Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 164.47 % |
| Y-o-Y | -22.52 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Dec2025 | ₹3 Cr | 164.47 | |
| Sep2025 | ₹1 Cr | -71.84 | |
| Jun2025 | ₹4 Cr | -66.96 | |
| Mar2025 | ₹13 Cr | 214.85 | |
| Dec2024 | ₹4 Cr | -62.34 | |
| Sep2024 | ₹11 Cr | 4.97 | |
| Jun2024 | ₹10 Cr | -25.10 | |
| Mar2024 | ₹13 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 104.81 % |
| Y-o-Y | -21.69 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Dec2025 | 4.26% | 104.81 | |
| Sep2025 | 2.08% | -64.51 | |
| Jun2025 | 5.86% | -64.40 | |
| Mar2025 | 16.46% | 202.57 | |
| Dec2024 | 5.44% | -60.23 | |
| Sep2024 | 13.68% | -11.00 | |
| Jun2024 | 15.37% | -31.72 | |
| Mar2024 | 22.51% | - | |
BALAXI PHARMACEUTICALS Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 46.15 % |
| Y-o-Y | -94.33 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Dec2025 | ₹0 Cr | 46.15 | |
| Sep2025 | ₹0 Cr | -28.52 | |
| Jun2025 | ₹0 Cr | -96.63 | |
| Mar2025 | ₹9 Cr | 61.10 | |
| Dec2024 | ₹5 Cr | 16.87 | |
| Sep2024 | ₹5 Cr | -29.20 | |
| Jun2024 | ₹6 Cr | -40.73 | |
| Mar2024 | ₹11 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | 13.51 % |
| Y-o-Y | -94.26 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Dec2025 | 0.42 % | 13.51 | |
| Sep2025 | 0.37 % | -9.76 | |
| Jun2025 | 0.41 % | -96.38 | |
| Mar2025 | 11.33 % | 54.78 | |
| Dec2024 | 7.32 % | 23.44 | |
| Sep2024 | 5.93 % | -39.92 | |
| Jun2024 | 9.87 % | -45.98 | |
| Mar2024 | 18.27 % | - | |
BALAXI PHARMACEUTICALS Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | 50.00 % |
| Y-o-Y | -93.81 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Dec2025 | ₹0.06 | 50.00 | |
| Sep2025 | ₹0.04 | -20.00 | |
| Jun2025 | ₹0.05 | -96.79 | |
| Mar2025 | ₹1.56 | 60.82 | |
| Dec2024 | ₹0.97 | 16.87 | |
| Sep2024 | ₹0.83 | -29.06 | |
| Jun2024 | ₹1.17 | -41.79 | |
| Mar2024 | ₹2.01 | - | |
You may also like the below Video Courses
ADANI ENTERPRISES LTD vs REDINGTON LTD vs MMTC LTD
HONASA CONSUMER LTD vs LLOYDS ENTERPRISES LTD vs ENTERO HEALTHCARE SOLUTIONS LTD